Global Roundup: Overland Pharma Launches in China to Provide Access to Breakthrough Therapies
The Pharma Data
DECEMBER 9, 2020
OHMX.bio – Belgium-based OHMX.bio and Fujirebio Europe were awarded a €720,000 research grant from Flanders Innovation & Entrepreneurship (VLAIO) to develop a clinical in vitro diagnostics (IVD) platform incorporating third generation sequencing (TGS) technologies. A solution could be at hand with Overland Pharmaceuticals.
Let's personalize your content